Literature DB >> 19243063

Questionnaire-based assessment of pelvic organ dysfunction in multiple system atrophy.

Tatsuya Yamamoto1, Ryuji Sakakibara, Tomoyuki Uchiyama, Zhi Liu, Takashi Ito, Yusuke Awa, Tomonori Yamanishi, Takamichi Hattori.   

Abstract

Multiple system atrophy (MSA) is a neurodegenerative disease characterized clinically by any combination of autonomic, cerebellar, and extrapyramidal symptoms. Autonomic symptoms are usually severe, and urinary symptoms are one of the cardinal features of MSA. Bowel dysfunction and sexual dysfunction are also common in MSA. Quality of life (QOL) in patients with MSA is severely impaired by the presence of pelvic organ dysfunction. Therefore, we aimed to examine the prevalence of pelvic organ dysfunction in patients with MSA. We recruited 256 patients with MSA seen at our neurology clinic. The mean age was 62 years. The control group comprised 158 individuals, and the mean age was 52 years. We administered a questionnaire on pelvic organ dysfunction to the MSA and control groups. The questionnaire had sections focusing on the bladder, bowel, and sexual function. Dysfunction, as described in the responses, was evaluated as normal, mild (>once a month), moderate (>once a week), or severe (>once a day). The Mann-Whitney's U-test was used for statistical analysis. When compared with the control group, the prevalence of pelvic organ dysfunction in the MSA group was significantly higher for urinary storage and voiding dysfunction, bowel dysfunction, and sexual dysfunction. QOL in the MSA group was therefore significantly impaired because of urinary dysfunction (70%, 76%), bowel dysfunction (40% of the men), and sexual dysfunction (26%, 45%). Pelvic organ dysfunction is common in MSA, and QOL is severely impaired in patients with MSA. (c) 2009 Movement Disorder Society.

Entities:  

Mesh:

Year:  2009        PMID: 19243063     DOI: 10.1002/mds.22332

Source DB:  PubMed          Journal:  Mov Disord        ISSN: 0885-3185            Impact factor:   10.338


  7 in total

1.  Association between cognitive impairment and urinary dysfunction in Parkinson's disease.

Authors:  Zuzanna Tkaczynska; Andrea Pilotto; Sara Becker; Susanne Gräber-Sultan; Daniela Berg; Inga Liepelt-Scarfone
Journal:  J Neural Transm (Vienna)       Date:  2017-02-17       Impact factor: 3.575

Review 2.  Urological dysfunction in synucleinopathies: epidemiology, pathophysiology and management.

Authors:  Ryuji Sakakibara; Fuyuki Tateno; Tatsuya Yamamoto; Tomoyuki Uchiyama; Tomonori Yamanishi
Journal:  Clin Auton Res       Date:  2017-11-09       Impact factor: 4.435

3.  The close relationship between life-threatening breathing disorders and urine storage dysfunction in multiple system atrophy.

Authors:  Kazushi Deguchi; Kazuyo Ikeda; Rieko Goto; Masago Tsukaguchi; Yoshiteru Urai; Kazutaka Kurokohchi; Tetsuo Touge; Nozomu Mori; Tsutomu Masaki
Journal:  J Neurol       Date:  2010-03-05       Impact factor: 4.849

4.  Autopsy confirmed multiple system atrophy cases: Mayo experience and role of autonomic function tests.

Authors:  Valeria Iodice; Axel Lipp; J Eric Ahlskog; Paola Sandroni; Robert D Fealey; Joseph E Parisi; Joseph Y Matsumoto; Eduardo E Benarroch; Kurt Kimpinski; Wolfgang Singer; Tonette L Gehrking; Jade A Gehrking; David M Sletten; Ann M Schmeichel; James H Bower; Sid Gilman; Juan Figueroa; Phillip A Low
Journal:  J Neurol Neurosurg Psychiatry       Date:  2012-01-06       Impact factor: 10.154

5.  Bladder and bowel symptoms among adults presenting with low back pain to an academic chiropractic clinic: results of a preliminary study.

Authors:  Anna L Walden; Stacie A Salsbury; William R Reed; Dana J Lawrence
Journal:  J Chiropr Med       Date:  2014-09

6.  Autonomic dysfunctions in parkinsonian disorders.

Authors:  Hyo-Jin Bae; Sang-Myung Cheon; Jae Woo Kim
Journal:  J Mov Disord       Date:  2009-10-30

7.  Urinary Dysfunctions Are More Severe in the Parkinsonian Phenotype of Multiple System Atrophy.

Authors:  Tatsuya Yamamoto; Masato Asahina; Yoshitaka Yamanaka; Tomoyuki Uchiyama; Shigeki Hirano; Atsuhiko Sugiyama; Ryuji Sakakibara; Satoshi Kuwabara
Journal:  Mov Disord Clin Pract       Date:  2016-01-27
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.